| JYHB2100231 | 巴瑞替尼片 | baricitinib | Tablet | Chemical Drugs | Supplementary Application | 2021-03-31 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | In Review | 2021-03-30 | view |
| JYHB2100230 | 巴瑞替尼片 | baricitinib | Tablet | Chemical Drugs | Supplementary Application | 2021-03-31 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | In Review | 2021-03-30 | view |
| JYHB2002158 | 他达拉非片 | tadalafil | Tablet | Chemical Drugs(1) | Supplementary Application | 2020-10-27 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | Filed | 2020-11-09 | view |
| JYHB2002157 | 他达拉非片 | tadalafil | Tablet | Chemical Drugs | Supplementary Application | 2020-10-27 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | Filed | 2020-11-16 | view |
| JYSB2000469 | 精蛋白锌重组赖脯胰岛素混合注射液(50R) | | Injection | Biological Products | Supplementary Application | 2020-09-23 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | Certificate Issued | 2020-11-20 | view |
| JYSB2000468 | 精蛋白锌重组赖脯胰岛素混合注射液(50R) | | Injection | Biological Products | Supplementary Application | 2020-09-23 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | Certificate Issued | 2020-11-20 | view |
| JYSB2000444 | 精蛋白锌重组赖脯胰岛素混合注射液(50R) | | Injection | Biological Products | Supplementary Application | 2020-09-08 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | Filed | 2020-09-18 | view |
| JYSB2000443 | 精蛋白锌重组赖脯胰岛素混合注射液(50R) | | Injection | Biological Products | Supplementary Application | 2020-09-08 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | Filed | 2020-09-18 | view |
| JYSB2000419 | 度拉糖肽注射液 | dulaglutide | Injection | Biological Products | Supplementary Application | 2020-08-24 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | Filed | 2020-09-02 | view |
| JYSB2000418 | 度拉糖肽注射液 | dulaglutide | Injection | Biological Products | Supplementary Application | 2020-08-24 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | Filed | 2020-09-02 | view |
| JYHB2001429 | 他达拉非片 | tadalafil | Tablet | Chemical Drugs | Supplementary Application | 2020-08-21 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | Filed | 2020-09-01 | view |
| JYSB2000385 | 特立帕肽注射液 | teriparatide | Injection | Biological Products | Supplementary Application | 2020-08-21 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | Filed | 2020-09-02 | view |
| JYHB2001432 | 他达拉非片 | tadalafil | Tablet | Chemical Drugs | Supplementary Application | 2020-08-21 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | Filed | 2020-09-01 | view |
| JYHB2001431 | 他达拉非片 | tadalafil | Tablet | Chemical Drugs | Supplementary Application | 2020-08-21 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | Filed | 2020-09-01 | view |
| JYHB2001430 | 他达拉非片 | tadalafil | Tablet | Chemical Drugs | Supplementary Application | 2020-08-21 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | Filed | 2020-09-01 | view |
| JYHB2001331 | 盐酸雷洛昔芬片 | raloxifene hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2020-08-10 | Eli Lilly Nederland B.V | Eli Lilly Nederland BV | Filed | 2020-08-21 | view |
| JYHB2001278 | 巴瑞替尼片 | baricitinib | Tablet | Chemical Drugs | Supplementary Application | 2020-08-06 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | Filed | 2020-08-19 | view |
| JYHB2001161 | 巴瑞替尼片 | baricitinib | Tablet | Chemical Drugs | Supplementary Application | 2020-07-04 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | Certificate Issued | 2020-12-10 | view |
| JYHB2001160 | 巴瑞替尼片 | baricitinib | Tablet | Chemical Drugs | Supplementary Application | 2020-07-04 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | Certificate Issued | 2020-12-10 | view |
| JYSB2000293 | 精蛋白锌重组赖脯胰岛素混合注射液(50R) | | Injection | Biological Products | Supplementary Application | 2020-06-22 | Eli Lilly Nederland B.V. | Eli Lilly Nederland BV | Filed | 2020-06-24 | view |
